BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26186508)

  • 1. Shedding light on prion disease.
    Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
    Prion; 2015; 9(4):244-56. PubMed ID: 26186508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
    Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
    FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sheddase ADAM10 is a potent modulator of prion disease.
    Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
    Elife; 2015 Feb; 4():. PubMed ID: 25654651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
    Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
    J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Cleavage of cellular prion protein.
    Liang J; Kong Q
    Prion; 2012; 6(5):453-60. PubMed ID: 23052041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized Western blot assay provides a comprehensive assessment of the physiological endoproteolytic processing of the prion protein.
    Vanni I; Iacobone F; D'Agostino C; Giovannelli M; Pirisinu L; Altmeppen HC; Castilla J; Torres JM; Agrimi U; Nonno R
    J Biol Chem; 2023 Feb; 299(2):102823. PubMed ID: 36565989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.
    Linsenmeier L; Mohammadi B; Wetzel S; Puig B; Jackson WS; Hartmann A; Uchiyama K; Sakaguchi S; Endres K; Tatzelt J; Saftig P; Glatzel M; Altmeppen HC
    Mol Neurodegener; 2018 Apr; 13(1):18. PubMed ID: 29625583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.
    Liang J; Wang W; Sorensen D; Medina S; Ilchenko S; Kiselar J; Surewicz WK; Booth SA; Kong Q
    J Biol Chem; 2012 May; 287(20):16510-20. PubMed ID: 22447932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic processing of the prion protein in health and disease.
    Altmeppen HC; Puig B; Dohler F; Thurm DK; Falker C; Krasemann S; Glatzel M
    Am J Neurodegener Dis; 2012; 1(1):15-31. PubMed ID: 23383379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P's and Q's of cellular PrP-Aβ interactions.
    Westaway D; Jhamandas JH
    Prion; 2012; 6(4):359-63. PubMed ID: 22874673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new paradigm for enzymatic control of α-cleavage and β-cleavage of the prion protein.
    McDonald AJ; Dibble JP; Evans EG; Millhauser GL
    J Biol Chem; 2014 Jan; 289(2):803-13. PubMed ID: 24247244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor-1 α regulates prion protein expression to protect against neuron cell damage.
    Jeong JK; Seo JS; Moon MH; Lee YJ; Seol JW; Park SY
    Neurobiol Aging; 2012 May; 33(5):1006.e1-10. PubMed ID: 22036844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases.
    Béland M; Roucou X
    Prion; 2014; 8(1):106-10. PubMed ID: 24335160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.
    Mohammadi B; Song F; Matamoros-Angles A; Shafiq M; Damme M; Puig B; Glatzel M; Altmeppen HC
    Cell Tissue Res; 2023 Apr; 392(1):215-234. PubMed ID: 35084572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
    Iraci N; Stincardini C; Barreca ML; Biasini E
    Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo.
    Altmeppen HC; Prox J; Puig B; Kluth MA; Bernreuther C; Thurm D; Jorissen E; Petrowitz B; Bartsch U; De Strooper B; Saftig P; Glatzel M
    Mol Neurodegener; 2011 May; 6():36. PubMed ID: 21619641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse functions of the prion protein - Does proteolytic processing hold the key?
    Linsenmeier L; Altmeppen HC; Wetzel S; Mohammadi B; Saftig P; Glatzel M
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2128-2137. PubMed ID: 28693923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental expression and localization of the cellular prion protein in the central nervous system of the mouse.
    Benvegnù S; Poggiolini I; Legname G
    J Comp Neurol; 2010 Jun; 518(11):1879-91. PubMed ID: 20394048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts.
    Matamoros-Angles A; Mohammadi B; Song F; Shafiq M; Brenna S; Puig B; Glatzel M; Altmeppen HC
    Neural Regen Res; 2023 Sep; 18(9):1869-1875. PubMed ID: 36926701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.